Literature DB >> 2930574

Apparent "activation" of protein kinases by okadaic acid class tumor promoters.

T Sassa1, W W Richter, N Uda, M Suganuma, H Suguri, S Yoshizawa, M Hirota, H Fujiki.   

Abstract

A cytosolic fraction of mouse brain gave two peaks of protein kinase activity on DEAE-cellulose column chromatography. The first peak of protein kinase corresponded to protein kinase C. The second peak contained protein kinases that were "activated" dose-dependently by the okadaic acid class tumor promoters, okadaic acid and dinophysistoxin-1. This "activation" was not achieved by other tumor promoters, such as 12-0-tetradecanoyl-phorbol-13-acetate, teleocidin, aplysiatoxin, or palytoxin. In addition, the second peak contained phosphatases. The phosphate liberation from phosphorylated histone type III-S by incubation with the second peak was inhibited by okadaic acid or dinophysistoxin-1, dose-dependently. The resulting apparent "activation" of protein kinases by okadaic acid is indicated and would imply a new pathway of tumor promotion on mouse skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930574     DOI: 10.1016/0006-291x(89)92199-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.

Authors:  A Takai; M Murata; K Torigoe; M Isobe; G Mieskes; T Yasumoto
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases.

Authors:  S J Kim; R Lafyatis; K Y Kim; P Angel; H Fujiki; M Karin; M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-02

Review 3.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

4.  Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity.

Authors:  S Yoshizawa; R Matsushima; M F Watanabe; K Harada; A Ichihara; W W Carmichael; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Affinity of okadaic acid to type-1 and type-2A protein phosphatases is markedly reduced by oxidation of its 27-hydroxyl group.

Authors:  K Sasaki; M Murata; T Yasumoto; G Mieskes; A Takai
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

6.  Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Authors:  H Fujiki; M Suganuma; S Yoshizawa; S Nishiwaki; B Winyar; T Sugimura
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

7.  Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Authors:  K Nishio; Y Sugimoto; K Nakagawa; S Niimi; Y Fujiwara; M Bungo; K Kasahara; H Fujiki; N Saijo
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

Review 8.  Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.

Authors:  Miguel Medina; Jesús Avila; Nieves Villanueva
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

9.  Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1.

Authors:  A Sakai; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1991-05

10.  Okadaic acid is a potent angiogenesis inducer.

Authors:  T Oikawa; M Suganuma; H Ashino-Fuse; M Shimamura
Journal:  Jpn J Cancer Res       Date:  1992-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.